Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

  • Martin J. van den Bent
  • , Brigitta Baumert
  • , Sara C. Erridge
  • , Michael A. Vogelbaum
  • , Anna K. Nowak
  • , Marc Sanson
  • , Alba Ariela Brandes
  • , Paul M. Clement
  • , Jean Francais Baurain
  • , Warren P. Mason
  • , Helen Wheeler
  • , Olivier L. Chinot
  • , Sanjeev Gill
  • , Matthew Griffin
  • , David G. Brachman
  • , Walter Taal
  • , Roberta Rudà
  • , Michael Weller
  • , Catherine McBain
  • , Jaap Reijneveld
    • Roelien H. Enting, Damien C. Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Sarah Pascoe, Ulrich Herrlinger, Peter Hau, Frederic Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B. Jenkins, Hendrikus Jan Dubbink, Winand N.M. Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M. Kros

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

328 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study'. Samen vormen ze een unieke vingerafdruk.
Sorteer per

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience